These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26135558)
1. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry. Schoolmeester JK; Park KJ Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558 [TBL] [Abstract][Full Text] [Related]
2. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex. Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086 [TBL] [Abstract][Full Text] [Related]
3. Incidental lymphangioleiomyomatosis in the lymph nodes of gynecologic surgical specimens. Kuno I; Yoshida H; Shimizu H; Uehara T; Uno M; Ishikawa M; Kato T Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():93-97. PubMed ID: 30336310 [TBL] [Abstract][Full Text] [Related]
4. Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes. Moh M; Sangoi AR; Rabban JT Hum Pathol; 2017 Oct; 68():175-183. PubMed ID: 28899738 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological analysis of clinically occult extrapulmonary lymphangioleiomyomatosis in intra-pelvic and para-aortic lymph nodes associated with pelvic malignant tumors: A study of nine patients. Uehara K; Kawakami F; Hirose T; Morita H; Kudo E; Yasuda M; Märkl B; Zen Y; Itoh T; Imai Y Pathol Int; 2019 Jan; 69(1):29-36. PubMed ID: 30688413 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? Remo A; Zanella C; Parcesepe P; Greco F; Pancione M; Zapparoli MM; Manfrin E; Micheletto C Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):33-38. PubMed ID: 32476934 [TBL] [Abstract][Full Text] [Related]
7. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434 [TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor. Abdelkader A; Lam CA; Shahir KS; Christians K; Suster SM Ann Diagn Pathol; 2017 Apr; 27():69-73. PubMed ID: 28325364 [TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients. Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367 [TBL] [Abstract][Full Text] [Related]
10. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis. Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043 [TBL] [Abstract][Full Text] [Related]
12. Association of lymphangioleiomyomatosis (LAM) with endosalpingiosis in the retroperitoneal lymph nodes: report of two cases. Matsui K; Travis WD; Gonzalez R; Terzian JA; Rosai J; Moss J; Ferrans VJ Int J Surg Pathol; 2001 Apr; 9(2):155-62. PubMed ID: 11484504 [TBL] [Abstract][Full Text] [Related]
13. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses. Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436 [TBL] [Abstract][Full Text] [Related]
14. Spindle cell lesion on fine needle aspiration as an initial step for diagnosis of lymphangioleiomyomatosis: Report of a rare case. Manukyan I; Sidawy M; DeBrito P Diagn Cytopathol; 2021 Sep; 49(9):E352-E355. PubMed ID: 34000096 [TBL] [Abstract][Full Text] [Related]
15. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Djordjevic B; Malpica A Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998 [TBL] [Abstract][Full Text] [Related]
17. Cathepsin K is Superior to HMB45 for the Diagnosis of Pulmonary Lymphangioleiomyomatosis. Rolim I; Makupson M; Lovrenski A; Farver C Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):108-112. PubMed ID: 34433182 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report. De Rosa N Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis. Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]